- Home
- BLCO vs NXE Comparison
BLCO vs NXE Comparison
Compare BLCO & NXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLCO
- NXE
- Stock Information
- Founded
- BLCO 1853
- NXE 2011
- Country
- BLCO Canada
- NXE Canada
- Employees
- BLCO N/A
- NXE N/A
- Industry
- BLCO Ophthalmic Goods
- NXE
- Sector
- BLCO Health Care
- NXE
- Exchange
- BLCO Nasdaq
- NXE Nasdaq
- Market Cap
- BLCO 4.9B
- NXE 4.1B
- IPO Year
- BLCO 2022
- NXE N/A
- Fundamental
- Price
- BLCO $14.46
- NXE $6.95
- Analyst Decision
- BLCO Hold
- NXE
- Analyst Count
- BLCO 11
- NXE 0
- Target Price
- BLCO $15.80
- NXE N/A
- AVG Volume (30 Days)
- BLCO 952.3K
- NXE 7.5M
- Earning Date
- BLCO 07-30-2025
- NXE 08-07-2025
- Dividend Yield
- BLCO N/A
- NXE N/A
- EPS Growth
- BLCO N/A
- NXE N/A
- EPS
- BLCO N/A
- NXE N/A
- Revenue
- BLCO $4,891,000,000.00
- NXE N/A
- Revenue This Year
- BLCO $7.10
- NXE N/A
- Revenue Next Year
- BLCO $5.50
- NXE N/A
- P/E Ratio
- BLCO N/A
- NXE N/A
- Revenue Growth
- BLCO 8.81
- NXE N/A
- 52 Week Low
- BLCO $10.45
- NXE $3.91
- 52 Week High
- BLCO $21.69
- NXE $8.96
- Technical
- Relative Strength Index (RSI)
- BLCO 60.56
- NXE 53.61
- Support Level
- BLCO $13.09
- NXE $6.30
- Resistance Level
- BLCO $15.13
- NXE $7.45
- Average True Range (ATR)
- BLCO 0.58
- NXE 0.28
- MACD
- BLCO -0.08
- NXE -0.05
- Stochastic Oscillator
- BLCO 66.91
- NXE 56.77
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
About NXE Nexgen Energy Ltd.
NexGen Energy Ltd is a mineral exploration company. It is engaged in the acquisition, exploration, evaluation and development of uranium properties in Canada. The company's projects portfolio consists of ROOK I, and the IsoEnergy, at the Athabasca Basin. The Rook I property hosts the world-class Arrow Zone, the Bow discovery. as well as the discovered Harpoon area located northeast of the Arrow deposit.